440 related articles for article (PubMed ID: 19037805)
1. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
[TBL] [Abstract][Full Text] [Related]
2. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
[TBL] [Abstract][Full Text] [Related]
4. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.
Bree A; Schlerman FJ; Wadanoli M; Tchistiakova L; Marquette K; Tan XY; Jacobson BA; Widom A; Cook TA; Wood N; Vunnum S; Krykbaev R; Xu X; Donaldson DD; Goldman SJ; Sypek J; Kasaian MT
J Allergy Clin Immunol; 2007 May; 119(5):1251-7. PubMed ID: 17379289
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys.
Kasaian MT; Tan XY; Jin M; Fitz L; Marquette K; Wood N; Cook TA; Lee J; Widom A; Agostinelli R; Bree A; Schlerman FJ; Olland S; Wadanoli M; Sypek J; Gill D; Goldman SJ; Tchistiakova L
J Pharmacol Exp Ther; 2008 Jun; 325(3):882-92. PubMed ID: 18337474
[TBL] [Abstract][Full Text] [Related]
6. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice.
Ma Y; HayGlass KT; Becker AB; Fan Y; Yang X; Basu S; Srinivasan G; Simons FE; Halayko AJ; Peng Z
Am J Respir Crit Care Med; 2007 Sep; 176(5):439-45. PubMed ID: 17556715
[TBL] [Abstract][Full Text] [Related]
7. Effects of lactose-beta-sitosterol and beta-sitosterol on ovalbumin-induced lung inflammation in actively sensitized mice.
Yuk JE; Woo JS; Yun CY; Lee JS; Kim JH; Song GY; Yang EJ; Hur IK; Kim IS
Int Immunopharmacol; 2007 Dec; 7(12):1517-27. PubMed ID: 17920528
[TBL] [Abstract][Full Text] [Related]
8. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.
Katoh S; Matsumoto N; Kawakita K; Tominaga A; Kincade PW; Matsukura S
J Clin Invest; 2003 May; 111(10):1563-70. PubMed ID: 12750406
[TBL] [Abstract][Full Text] [Related]
9. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity.
Yang M; Hogan SP; Mahalingam S; Pope SM; Zimmermann N; Fulkerson P; Dent LA; Young IG; Matthaei KI; Rothenberg ME; Foster PS
J Allergy Clin Immunol; 2003 Nov; 112(5):935-43. PubMed ID: 14610483
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354).
Blanchard C; Mishra A; Saito-Akei H; Monk P; Anderson I; Rothenberg ME
Clin Exp Allergy; 2005 Aug; 35(8):1096-103. PubMed ID: 16120093
[TBL] [Abstract][Full Text] [Related]
11. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
Hirota JA; Ask K; Fritz D; Ellis R; Wattie J; Richards CD; Labiris R; Kolb M; Inman MD
Clin Exp Allergy; 2009 Jan; 39(1):147-58. PubMed ID: 19032363
[TBL] [Abstract][Full Text] [Related]
12. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.
Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T
Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862
[TBL] [Abstract][Full Text] [Related]
13. [Anti-inflammatory and anti-allergic effects of acidic fraction of Pheratima extract in asthma mice induced by ovalbumin].
Zhou MM; Chu XP; Yang HZ; Kou F; Zhao AH; Jia W
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2249-52. PubMed ID: 19166019
[TBL] [Abstract][Full Text] [Related]
14. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
Mitchell J; Dimov V; Townley RG
Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
[TBL] [Abstract][Full Text] [Related]
15. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
16. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma.
Tomkinson A; Tepper J; Morton M; Bowden A; Stevens L; Harris P; Lindell D; Fitch N; Gundel R; Getz EB
Allergy; 2010 Jan; 65(1):69-77. PubMed ID: 19796211
[TBL] [Abstract][Full Text] [Related]
17. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects.
Colavita AM; Hastie AT; Musani AI; Pascual RM; Reinach AJ; Lustine HT; Galati SA; Zangrilli JG; Fish JE; Peters SP
J Allergy Clin Immunol; 2000 Nov; 106(5):880-6. PubMed ID: 11080710
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
Owen CE
Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
[TBL] [Abstract][Full Text] [Related]
20. [Polynuclear basophils, the key to allergic reactions. Modulations by chemokines].
Devouassoux G
Rev Mal Respir; 2000 Jun; 17(3):629-40. PubMed ID: 10951958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
